Article Type
Changed
Wed, 10/18/2023 - 09:55
Display Headline
Long COVID: Advocating for Patients and Implementing Effective Techniques
References

1. Lutchmansingh DD et al. Semin Respir Crit Care Med. 2023;44(1):130-142. doi:10.1055/s-0042-1759568
2. Davis HE et al. Nat Rev Microbiol. 2023;21(3):133-146. doi:10.1038/s41579-022-00846-2
3. Ahmed H et al. J Rehabil Med. 2020;52(5):jrm00063. doi:10.2340/16501977-2694
4. Resources. Long COVID Physio. Accessed May 31, 2023. https://longcovid.physio/resources
5. Long COVID: What do the latest data show? KFF. Published January 26, 2023. Accessed May 31, 2023. https://www.kff.org/policy-watch/long-covid-what-do-latest-data-show/
6. Castanares-Zapatero D et al. Ann Med. 2022;54(1):1473-1487. doi:10.1080/07853890.2022.2076901
7. Mehandru S, Merad M. Nat Immunol. 2022;23(2):194-202. doi:10.1038/s41590-021-01104-y
8. Dhooria S et al. Eur Respir J. 2022;59(2):2102930. doi:10.1183/13993003.02930-2021
9. Researching COVID to enhance recovery. RECOVER. Accessed May 31, 2023. https://recovercovid.org/

Author and Disclosure Information

Kyle B. Enfield, MD, MS, FSHEA, FCCM
Associate Professor of Medicine
Vice Chair, Quality Improvement and Patient Safety
University of Virginia;
Associate Chief Medical Officer, Critical Care
Department of Medicine
University of Virginia Health System
Charlottesville, VA

Publications
Topics
Author and Disclosure Information

Kyle B. Enfield, MD, MS, FSHEA, FCCM
Associate Professor of Medicine
Vice Chair, Quality Improvement and Patient Safety
University of Virginia;
Associate Chief Medical Officer, Critical Care
Department of Medicine
University of Virginia Health System
Charlottesville, VA

Author and Disclosure Information

Kyle B. Enfield, MD, MS, FSHEA, FCCM
Associate Professor of Medicine
Vice Chair, Quality Improvement and Patient Safety
University of Virginia;
Associate Chief Medical Officer, Critical Care
Department of Medicine
University of Virginia Health System
Charlottesville, VA

References

1. Lutchmansingh DD et al. Semin Respir Crit Care Med. 2023;44(1):130-142. doi:10.1055/s-0042-1759568
2. Davis HE et al. Nat Rev Microbiol. 2023;21(3):133-146. doi:10.1038/s41579-022-00846-2
3. Ahmed H et al. J Rehabil Med. 2020;52(5):jrm00063. doi:10.2340/16501977-2694
4. Resources. Long COVID Physio. Accessed May 31, 2023. https://longcovid.physio/resources
5. Long COVID: What do the latest data show? KFF. Published January 26, 2023. Accessed May 31, 2023. https://www.kff.org/policy-watch/long-covid-what-do-latest-data-show/
6. Castanares-Zapatero D et al. Ann Med. 2022;54(1):1473-1487. doi:10.1080/07853890.2022.2076901
7. Mehandru S, Merad M. Nat Immunol. 2022;23(2):194-202. doi:10.1038/s41590-021-01104-y
8. Dhooria S et al. Eur Respir J. 2022;59(2):2102930. doi:10.1183/13993003.02930-2021
9. Researching COVID to enhance recovery. RECOVER. Accessed May 31, 2023. https://recovercovid.org/

References

1. Lutchmansingh DD et al. Semin Respir Crit Care Med. 2023;44(1):130-142. doi:10.1055/s-0042-1759568
2. Davis HE et al. Nat Rev Microbiol. 2023;21(3):133-146. doi:10.1038/s41579-022-00846-2
3. Ahmed H et al. J Rehabil Med. 2020;52(5):jrm00063. doi:10.2340/16501977-2694
4. Resources. Long COVID Physio. Accessed May 31, 2023. https://longcovid.physio/resources
5. Long COVID: What do the latest data show? KFF. Published January 26, 2023. Accessed May 31, 2023. https://www.kff.org/policy-watch/long-covid-what-do-latest-data-show/
6. Castanares-Zapatero D et al. Ann Med. 2022;54(1):1473-1487. doi:10.1080/07853890.2022.2076901
7. Mehandru S, Merad M. Nat Immunol. 2022;23(2):194-202. doi:10.1038/s41590-021-01104-y
8. Dhooria S et al. Eur Respir J. 2022;59(2):2102930. doi:10.1183/13993003.02930-2021
9. Researching COVID to enhance recovery. RECOVER. Accessed May 31, 2023. https://recovercovid.org/

Publications
Publications
Topics
Article Type
Display Headline
Long COVID: Advocating for Patients and Implementing Effective Techniques
Display Headline
Long COVID: Advocating for Patients and Implementing Effective Techniques
Disallow All Ads
Content Gating
Open Access (article Unlocked/Open Access)
Alternative CME
Disqus Comments
Default
Eyebrow Default
Slideshow
Gate On Date
Fri, 09/22/2023 - 17:30
Un-Gate On Date
Fri, 09/22/2023 - 17:30
Use ProPublica
CFC Schedule Remove Status
Fri, 09/22/2023 - 17:30
Hide sidebar & use full width
Do not render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Article Slideshow Optional Introduction

Slideshow below.

While definitions of postacute sequelae of SARS-CoV-2 (PASC), commonly referred to as long COVID, are heterogeneous, it is internationally recognized that some patients have symptoms that persist after recovery from their acute illness.1,2 Most clinicians agree that this disease manifestation begins at around 60 to 90 days after original COVID-19 infection, based on the World Health Organization (WHO) definition.1 Long COVID has similarities to postviral infections seen in SARS, MERS, Ebola, and West Nile virus.1,3 Theories on its potential cause include ongoing inflammation and autoimmunity, among other theories.1,2

Currently, no FDA-approved treatments are available for long COVID and most patients are receiving variable care with off-label use of drugs.1 Multiple clinical trials are in early stages. Certain nonpharmacological approaches have been effective for 2 common lingering long COVID symptoms: exercise intolerance and fatigue.4 These techniques provide patients with tips to help manage decreased energy levels and provide breathing exercises for patients experiencing exercise intolerance.4

Long COVID is a challenge for the medical community, but progress is being made in pinpointing causes, effective treatments, and techniques to help people who continue to have symptoms after having had COVID-19.1,4

Slide
Medscape Article
Display survey writer
Reuters content
Disable Inline Native ads
WebMD Article
Slide Media